Tapestry Pharmaceuticals
4840 Pearl East Circle
Suite 300 W
Boulder,
CO 80301-2408
United States - Map
Phone: 303-516-8500
Fax: 303-530-1296
Web Site: http://www.tapestrypharma.com
| Index Membership: | N/A | | Sector: | N/A | | Industry: | N/A | | Full Time Employees: | 32 |
|
| Tapestry Pharmaceuticals, Inc., together with its subsidiaries, focuses on the development of proprietary therapies for the treatment of cancer. It also engages in evaluating new therapeutic agents and/or related technologies that involve the examination of individual molecules, classes of compounds, or platform technologies. The company provides therapeutic candidate programs, including TPI 287 IV and TIP 287 oral formulations for prostate, non-small cell lung, and other cancers. Tapestry Pharmaceuticals was founded in 1991 and is based in Boulder, Colorado. On March 19, 2009, Tapestry Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Colorado. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Leonard P. Shaykin , 63
Exec. Chairman |
N/A
| N/A | Mr. Gordon H. Link Jr., 55
Chief Exec. Officer, Chief Financial Officer, Sr. VP |
N/A
| N/A | Dr. Patricia A. Pilia Ph.D., 60
Co-Founder, Director and Member of R&D Committee |
N/A
| N/A | Mr. Martin M. Batt , 66
Chief Operating Officer and Sr. VP |
N/A
| N/A | Mr. Kai P. Larson Esq., 45
VP, Gen. Counsel and Sec. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-06
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
Profile
